QMS Medical Allied Services Ltd
Pharmaceuticals & Biotechnology | Small Cap
QMS Medical Allied Services Ltd, operating in the Healthcare Services sector, displays a mixed financial profile. The company shows strong profitability, driven by healthy gross profit and operating margins. Its solvency position appears reasonable, indicating a manageable debt level relative to its equity and assets. However, liquidity is a significant concern due to very low current, quick, and cash ratios. The company's growth metrics are also weak, with substantial declines in revenue, operating profit, EPS, and net income. While the coverage ratios suggest some ability to meet interest and dividend obligations, the overall financial health is challenged by poor liquidity and negative growth trends. The high score is mainly due to the high solvency, profitability and coverage ratios which is offset by the poor liquidity and growth ratios.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.00
- Financial Ratio3.60
- Profitability Ratio5.60
- Efficiency Ratio4.67
- Coverage Ratio4.80
- Solvency Ratio8.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayStrong Bullish
- 1 WeekBullish
- 1 MonthNeutral
QMS Medical Allied Services Ltd, operating in the Healthcare Services sector, displays a mixed financial profile. The company shows strong profitability, driven by healthy gross profit and operating margins. Its solvency position appears reasonable, indicating a manageable debt level relative to its equity and assets. However, liquidity is a significant concern due to very low current, quick, and cash ratios. The company's growth metrics are also weak, with substantial declines in revenue, operating profit, EPS, and net income. While the coverage ratios suggest some ability to meet interest and dividend obligations, the overall financial health is challenged by poor liquidity and negative growth trends. The high score is mainly due to the high solvency, profitability and coverage ratios which is offset by the poor liquidity and growth ratios.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
31.62
Industry Median
40.10
Small Cap Median
40.10
P/E RATIO
20.88
P/B RATIO
2.03
Industry Median
2.18
Small Cap Median
2.18
P/S RATIO
1.18
Industry Median
2.34
Small Cap Median
2.34
Others
PEG RATIO
0.00
EV/EBITDA RATIO
7.54
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹109.4 as on Jun 17, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Concall Report⬤9th Jun 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
The growth ratios indicate a significant contraction in the company's performance. The weighted average calculation highlights the recent sharp declines in key growth metrics. While the healthcare industry can be subject to fluctuations, these trends raise concerns about the company's competitive positioning and future prospects.
| Growth Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue Growth Rate | 27.87 | 10.9 | |
| Operating Profit Growth Rate | 38.89 | 4 | |
| Earnings Per Share (EPS) Growth | 34.33 | -16.29 | |
| Asset Growth Rate | 40.74 | 12.11 | |
| Net Income Growth Rate | 55.56 | -14.29 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios present a mixed view. While capital expenditures are well-managed, the very low adjusted EPS, cash EPS, and book value per share. The weighted average calculation balances these factors. Overall, the company's financial performance is moderate, with several areas needing significant improvement to enhance long-term sustainability.
| Financial Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 5 | 8.67 | 7.25 |
| Cash Earnings Per Share (Cash EPS) | 6.67 | 10 | 8.42 |
| Book Value Per Share | 43.89 | 50 | 54.74 |
| Dividend Per Share (DPS) | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 0 | 0.1 | 0 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios present a mixed picture. While the gross profit margin, operating margin, and net margin are strong, the Return ratios are poor. The weighted average calculation highlights the balance between these factors. Overall, the company exhibits moderate efficiency in its operations, with room for improvement in several key areas.
| Profitability Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Gross Profit Margin | 12.3 | 13.46 | 12.72 |
| Return on Capital Employed (ROCE) | 18.52 | 17 | 13 |
| Return on Equity (ROE) | 11.39 | 15.56 | 11.54 |
| Return on Assets (ROA) | 13.33 | 13.16 | 12.21 |
| Operating Margin | 14.75 | 16.03 | 15.03 |
| Net Margin | 7.38 | 8.97 | 6.94 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed picture. While the days sales in inventory and receivable days are high, indicating efficient management of these aspects, the other ratios are poor. The weighted average methodology captures the balance between these factors. Overall, the company exhibits moderate efficiency in its operations, with room for improvement in several key areas.
| Efficiency Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Fixed Asset Turnover Ratio | 5.08 | 2.94 | 3.04 |
| Inventory Turnover Ratio | 2.82 | 3.48 | 3.55 |
| Receivables Turnover Ratio | 2.94 | 3.71 | 3.15 |
| Days Sales in Inventory Ratio | 129.43 | 104.89 | 102.82 |
| Receivable Days | 124 | 98.38 | 115.87 |
| Capital Turnover Ratio | 1.51 | 1.58 | 1.66 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios suggest that the company has some capacity to meet its interest and dividend obligations. The weighted average calculation indicates a reasonable ability to cover these expenses. However, given the other financial challenges, maintaining these ratios will be crucial for ensuring financial stability.
| Coverage Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Interest Coverage Ratio | 5 | 4.8 | 3.29 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is strong, suggesting a low risk of financial distress. Although the equity ratio is low, the other ratios indicate that the company has a conservative debt management approach. The weighted average calculation reflects a consistent approach to maintaining a balanced capital structure. This provides a stable foundation for future growth and investment.
| Solvency Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debt Ratio | 0.02 | 0.09 | 0 |
| Debt to Equity Ratio | 0.02 | 0.1 | 0 |
| Equity Ratio | 0.98 | 0.91 | 1 |
| Debt To Asset Ratio | 0.01 | 0.05 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position is concerning. The company may face difficulties in meeting its short-term obligations if current assets are not readily convertible into cash. While a conservative approach to liquidity can reduce risk, the current levels may be overly restrictive and could limit operational flexibility. The weighted average calculation emphasizes recent performance, highlighting the persistent liquidity challenges.
| Liquidity Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Current Ratio | 2 | 1.44 | 1.38 |
| Quick Ratio | 1.3 | 1.01 | 0.95 |
| Cash Ratio | 0 | 0.01 | 0.01 |
| Operating Cash Flow Ratio | 0.02 | 0.22 | 0.17 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Mohini Health & Hygiene Ltd | 4.51 | -3.19 | Neutral | -3.00 | -8.32 | -17.00 |
| 2 | QMS Medical Allied Services Ltd | 4.09 | 20.88 | Neutral | 26.00 | 3.46 | 12.00 |
The management of QMS Medical Allied Services exhibits a mixed performance. The company demonstrates robust revenue growth, with a Compounded Sales Growth of 28% (TTM). Promoter holding remains consistently high at 73.67%. However, there are concerns regarding increasing borrowings and inconsistent dividend payouts. The high cash conversion cycle also suggests potential inefficiencies in working capital management. Overall, the management shows strengths in revenue generation but needs to address financial prudence and operational efficiency for long-term sustainability.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Compounded Sales Growth (TTM) | 28% | Strong revenue expansion |
| Promoter Holding | 73.67% | High promoter confidence | |
| CONS | Borrowings (Mar 2025) | ₹ 51 Cr. | Increased financial leverage |
| Dividend Payout (Mar 2025) | 0% | Inconsistent shareholder returns |
Financial Performance & Growth
QMS Medical Allied Services shows robust revenue expansion, with a Compounded Sales Growth of 28% (TTM) and YOY Sales Growth of 27.74%. This indicates the company's ability to increase sales. OPM is stable at 15% (Mar 2024) and 16% (Mar 2025), demonstrating operational efficiency. The increasing other income from 0.46 (Mar 2024) to 1.72 (Mar 2025) contributes positively to net profit.
| Metric | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 35.24 | 32.29 | 37.20 | 43.87 | 44.58 |
| YOY Sales Growth % | 24.49% | 38.06% | |||
| Operating Profit | 4.84 | 3.95 | 7.24 | 6.94 | 6.37 |
| OPM % | 13.73% | 12.23% | 19.46% | 15.82% | 14.29% |
Capital Efficiency & Returns
The company has a ROCE of 17% (Mar 2025) and an ROE of 12.09. However, the high Cash Conversion Cycle of 201 days suggests inefficiency in working capital management, which can tie up capital and reduce financial flexibility.
| Metric | Mar 2024 | Mar 2025 | |---|---| | ROCE % | | 17% | | Debtor Days | 124 | 101 | | Inventory Days | 172 | 176 | | Days Payable | 90 | 76 | | Cash Conversion Cycle | 205 | 201 |
Financial Health & Prudence
Borrowings have increased from ₹32 Cr. (Mar 2024) to ₹51 Cr. (Mar 2025), raising concerns about increasing financial leverage. The dividend payout was 10% (Mar 2024) but 0% (Mar 2025), indicating inconsistency in sharing profits with shareholders. The interest has increased from ₹3 Cr. (Mar 2024) to ₹5 Cr. (Mar 2025).
| Metric | Mar 2024 | Mar 2025 | |---|---| | Borrowings | 32 | 51 | | Dividend Payout % | 10% | 0% | | Interest | 3 | 5 |
Shareholding & Ownership Structure
Promoter holding is consistently high at 73.67% from Mar 2023 to Mar 2025, indicating strong confidence. FII holding is minimal at 0.01%.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Promoter Holding | 73.67% | 73.67% | 73.67% |
| FII Holding | 1.21% | 0.01% | 0.01% |
QMS Medical Allied Services faces moderate risk. While the company exhibits strong revenue growth and consistent promoter holding, increasing borrowings and a high cash conversion cycle present financial and operational challenges. The volatility in quarterly profit growth and minimal FII holding also contribute to the risk profile. Overall, the company needs to manage its financial leverage and improve working capital efficiency to reduce risk.
Off-balance sheet exposure quantification
There is no specific data available on off-balance sheet exposure quantification.
Contingent liability evaluation
There is no specific data available on contingent liability evaluation.
Foreign exchange or interest rate exposure
There is no specific data available on foreign exchange or interest rate exposure.
Regulatory compliance cost trends
There is no specific data available on regulatory compliance cost trends.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10102.98Bullish
- SMA 2099.20Bullish
- SMA 5095.11Bullish
- EMA 10103.87Bullish
- EMA 20100.54Bullish
- EMA 5096.02Bullish
- DEMA 10107.96Bullish
- DEMA 20105.18Bullish
- DEMA 50100.96Bullish
- TEMA 10109.28Bullish
- TEMA 20107.41Bullish
- TEMA 50103.33Bullish
- MACD3.76Bullish
- ADX30.91Strong Trend
- IndicatorValueSignal
- RSI76.72Overbought
- CCI163.17Overbought
- ROC 913.15Bullish
- ROC 1416.42Bullish
- ROC 2522.21Bullish
- Stoch K84.94Overbought
- Stoch D86.18Overbought
- IndicatorValueSignal
- BB Upper109.46Overbought
- BB Middle99.20Neutral
- BB Lower88.94Neutral
- ATR2.07High Volatility
- IndicatorValueSignal
- MFI81.35Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10100.31Bullish
- SMA 2096.78Bullish
- SMA 5092.22Bullish
- EMA 10101.92Bullish
- EMA 2098.40Bullish
- EMA 5093.70Bullish
- DEMA 10106.52Bullish
- DEMA 20103.22Bullish
- DEMA 5098.61Bullish
- TEMA 10108.60Bullish
- TEMA 20105.41Bullish
- TEMA 50101.29Bullish
- MACD3.93Bullish
- ADX30.53Strong Trend
- IndicatorValueSignal
- RSI75.64Overbought
- CCI227.56Overbought
- ROC 916.42Bullish
- ROC 1419.57Bullish
- ROC 2521.54Bullish
- Stoch K92.14Overbought
- Stoch D92.67Overbought
- IndicatorValueSignal
- BB Upper107.65Overbought
- BB Middle96.78Neutral
- BB Lower85.91Neutral
- ATR2.35High Volatility
- IndicatorValueSignal
- MFI83.97Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 1097.15Bullish
- SMA 2094.69Bullish
- SMA 5089.03Bullish
- EMA 1099.15Bullish
- EMA 2095.41Bullish
- EMA 5090.62Bullish
- DEMA 10104.07Bullish
- DEMA 20100.47Bullish
- DEMA 5095.59Bullish
- TEMA 10106.42Bullish
- TEMA 20103.07Bullish
- TEMA 50N/AN/A
- MACD4.14Bullish
- ADX26.15Strong Trend
- IndicatorValueSignal
- RSI77.00Overbought
- CCI325.53Overbought
- ROC 919.57Bullish
- ROC 1421.54Bullish
- ROC 2528.60Bullish
- Stoch K94.29Overbought
- Stoch D87.39Overbought
- IndicatorValueSignal
- BB Upper104.96Overbought
- BB Middle94.69Neutral
- BB Lower84.42Neutral
- ATR3.17High Volatility
- IndicatorValueSignal
- MFI95.45Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1092.03Bullish
- SMA 2088.22Bullish
- SMA 5085.25Bullish
- SMA 10086.10Bullish
- SMA 20089.40Bullish
- EMA 1092.54Bullish
- EMA 2090.11Bullish
- EMA 5087.51Bullish
- EMA 10087.46Bullish
- EMA 20089.55Bullish
- DEMA 1095.66Bullish
- DEMA 2093.38Bullish
- DEMA 5089.05Bullish
- DEMA 10086.16Bullish
- DEMA 20084.02Bullish
- TEMA 1096.89Bullish
- TEMA 2095.06Bullish
- TEMA 5091.86Bullish
- TEMA 10087.32Bullish
- TEMA 20086.56Bullish
- MACD2.67Bullish
- ADX18.02Weak Trend
- IndicatorValueSignal
- RSI66.48Neutral
- CCI128.17Overbought
- ROC 1416.17Bullish
- ROC 258.26Bullish
- Stoch K95.04Overbought
- Stoch D86.69Overbought
- IndicatorValueSignal
- BB Upper97.51Neutral
- BB Middle88.22Neutral
- BB Lower78.92Neutral
- ATR3.54Low Volatility
- IndicatorValueSignal
- MFI61.26Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2084.81Bullish
- SMA 5088.34Bullish
- EMA 2086.81Bullish
- EMA 5089.48Bullish
- DEMA 2086.50Bullish
- DEMA 5082.75Bullish
- TEMA 2088.45Bullish
- TEMA 5085.92Bullish
- MACD0.23Bullish
- ADX12.89Weak Trend
- IndicatorValueSignal
- RSI54.99Neutral
- CCI54.52Neutral
- ROC 1414.75Bullish
- ROC 251.38Bullish
- Stoch K87.37Overbought
- Stoch D74.18Neutral
- IndicatorValueSignal
- BB Upper96.33Neutral
- BB Middle84.81Neutral
- BB Lower73.29Neutral
- ATR7.88Low Volatility
- IndicatorValueSignal
- MFI76.46Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 685.53Bullish
- SMA 1287.91Bearish
- SMA 2496.81Bearish
- EMA 686.56Bullish
- EMA 1289.25Bearish
- EMA 2499.27Bearish
- DEMA 685.11Bullish
- DEMA 1282.52Bullish
- DEMA 24N/AN/A
- TEMA 685.80Bullish
- TEMA 1285.72Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX9.21Weak Trend
- IndicatorValueSignal
- RSI43.11Neutral
- CCIN/AN/A
- ROC 25-17.61Bearish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper113.29Neutral
- BB Middle91.45Neutral
- BB Lower69.61Neutral
- ATR21.91Low Volatility
- IndicatorValueSignal
- MFI66.12Neutral